Rank | Gene Set | Z-score |
---|---|---|
1 | locomotory exploration behavior (GO:0035641) | 5.78642339 |
2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.73014322 |
3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.54747982 |
4 | synaptic vesicle maturation (GO:0016188) | 5.50288365 |
5 | vocalization behavior (GO:0071625) | 5.10065565 |
6 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.09760637 |
7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.03242385 |
8 | glutamate secretion (GO:0014047) | 4.88791080 |
9 | synaptic vesicle exocytosis (GO:0016079) | 4.87796859 |
10 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.76528693 |
11 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.72846446 |
12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.71122847 |
13 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.58559907 |
14 | protein localization to synapse (GO:0035418) | 4.44605398 |
15 | exploration behavior (GO:0035640) | 4.32318146 |
16 | glutamate receptor signaling pathway (GO:0007215) | 4.26745282 |
17 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.22662681 |
18 | neuronal action potential propagation (GO:0019227) | 4.20273263 |
19 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.15332989 |
20 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.14517627 |
21 | synaptic transmission, glutamatergic (GO:0035249) | 4.14260099 |
22 | regulation of synaptic vesicle transport (GO:1902803) | 4.10309335 |
23 | layer formation in cerebral cortex (GO:0021819) | 3.99719866 |
24 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.95530820 |
25 | negative regulation of cell killing (GO:0031342) | 3.94959778 |
26 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.94959778 |
27 | regulation of synapse structural plasticity (GO:0051823) | 3.94672833 |
28 | long-term memory (GO:0007616) | 3.92042575 |
29 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.91112324 |
30 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.88953270 |
31 | neurotransmitter secretion (GO:0007269) | 3.85368758 |
32 | cellular potassium ion homeostasis (GO:0030007) | 3.81121964 |
33 | neuron-neuron synaptic transmission (GO:0007270) | 3.80269669 |
34 | neuron cell-cell adhesion (GO:0007158) | 3.79924415 |
35 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.76705662 |
36 | dendritic spine morphogenesis (GO:0060997) | 3.75762603 |
37 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.73300089 |
38 | regulation of postsynaptic membrane potential (GO:0060078) | 3.67132601 |
39 | germinal center formation (GO:0002467) | 3.62530056 |
40 | sodium ion export (GO:0071436) | 3.62065029 |
41 | positive regulation of synapse maturation (GO:0090129) | 3.59245757 |
42 | positive regulation of membrane potential (GO:0045838) | 3.58614548 |
43 | regulation of synaptic plasticity (GO:0048167) | 3.55709835 |
44 | long-term synaptic potentiation (GO:0060291) | 3.47207916 |
45 | proline transport (GO:0015824) | 3.46067339 |
46 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.45668046 |
47 | regulation of ARF protein signal transduction (GO:0032012) | 3.41444674 |
48 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.38284568 |
49 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.34780209 |
50 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.34178382 |
51 | activation of protein kinase A activity (GO:0034199) | 3.31198251 |
52 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.28730473 |
53 | gamma-aminobutyric acid transport (GO:0015812) | 3.28192102 |
54 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.27020317 |
55 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.26133396 |
56 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.25242619 |
57 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.24779485 |
58 | regulation of dendritic spine development (GO:0060998) | 3.24158686 |
59 | regulation of neurotransmitter secretion (GO:0046928) | 3.19314493 |
60 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.16624001 |
61 | neuromuscular process controlling balance (GO:0050885) | 3.16479308 |
62 | dendrite morphogenesis (GO:0048813) | 3.15361076 |
63 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.14497289 |
64 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.13869703 |
65 | postsynaptic membrane organization (GO:0001941) | 3.12279228 |
66 | neuron recognition (GO:0008038) | 3.09659122 |
67 | membrane depolarization (GO:0051899) | 3.09438440 |
68 | synaptic vesicle endocytosis (GO:0048488) | 3.09367675 |
69 | membrane depolarization during action potential (GO:0086010) | 3.07198071 |
70 | cell communication by electrical coupling (GO:0010644) | 3.06389650 |
71 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.06301059 |
72 | innervation (GO:0060384) | 3.05808329 |
73 | axonal fasciculation (GO:0007413) | 3.05550123 |
74 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.05243805 |
75 | regulation of gamma-delta T cell activation (GO:0046643) | 3.04757537 |
76 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.03212182 |
77 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.01066438 |
78 | chemosensory behavior (GO:0007635) | 3.00411878 |
79 | neurotransmitter transport (GO:0006836) | 2.97447923 |
80 | regulation of vesicle fusion (GO:0031338) | 2.95718822 |
81 | negative regulation of interleukin-12 production (GO:0032695) | 2.94765511 |
82 | long term synaptic depression (GO:0060292) | 2.94712206 |
83 | macrophage activation involved in immune response (GO:0002281) | 2.94116503 |
84 | response to histamine (GO:0034776) | 2.93623306 |
85 | positive regulation of dendritic spine development (GO:0060999) | 2.93054911 |
86 | dendritic spine organization (GO:0097061) | 2.92804969 |
87 | negative regulation of T cell mediated immunity (GO:0002710) | 2.92343452 |
88 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.92184782 |
89 | vesicle transport along microtubule (GO:0047496) | 2.92178540 |
90 | cerebellar granule cell differentiation (GO:0021707) | 2.91864507 |
91 | regulation of neurotransmitter transport (GO:0051588) | 2.90965851 |
92 | positive regulation of neurotransmitter transport (GO:0051590) | 2.90875367 |
93 | behavioral fear response (GO:0001662) | 2.89309025 |
94 | behavioral defense response (GO:0002209) | 2.89309025 |
95 | response to interleukin-15 (GO:0070672) | 2.89238648 |
96 | response to muramyl dipeptide (GO:0032495) | 2.88691389 |
97 | transmission of nerve impulse (GO:0019226) | 2.88650611 |
98 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.88022024 |
99 | positive regulation of synaptic transmission (GO:0050806) | 2.84774281 |
100 | positive T cell selection (GO:0043368) | 2.84753054 |
101 | learning (GO:0007612) | 2.84574934 |
102 | positive regulation of Rap GTPase activity (GO:0032854) | 2.83627665 |
103 | auditory behavior (GO:0031223) | 2.83605242 |
104 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.83096067 |
105 | negative T cell selection (GO:0043383) | 2.82087579 |
106 | negative thymic T cell selection (GO:0045060) | 2.81184557 |
107 | tolerance induction (GO:0002507) | 2.80579105 |
108 | regulation of synaptic transmission (GO:0050804) | 2.79817535 |
109 | presynaptic membrane assembly (GO:0097105) | 2.77088904 |
110 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.76721118 |
111 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.76698835 |
112 | L-amino acid import (GO:0043092) | 2.76549573 |
113 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.76529274 |
114 | regulation of neurotransmitter levels (GO:0001505) | 2.76001446 |
115 | establishment of nucleus localization (GO:0040023) | 2.75816794 |
116 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.75483794 |
117 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.75425050 |
118 | prepulse inhibition (GO:0060134) | 2.74773466 |
119 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.73571574 |
120 | fear response (GO:0042596) | 2.73093682 |
121 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.73059631 |
122 | cellular sodium ion homeostasis (GO:0006883) | 2.72200697 |
123 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.72195721 |
124 | nerve growth factor signaling pathway (GO:0038180) | 2.72159006 |
125 | membrane hyperpolarization (GO:0060081) | 2.72089415 |
126 | response to auditory stimulus (GO:0010996) | 2.71897773 |
127 | positive regulation of fibroblast migration (GO:0010763) | 2.71701111 |
128 | detection of calcium ion (GO:0005513) | 2.71457206 |
129 | cellular response to type I interferon (GO:0071357) | 2.70950044 |
130 | type I interferon signaling pathway (GO:0060337) | 2.70950044 |
131 | response to type I interferon (GO:0034340) | 2.69840483 |
132 | positive thymic T cell selection (GO:0045059) | 2.68338466 |
133 | cellular response to ethanol (GO:0071361) | 2.68207528 |
134 | T cell selection (GO:0045058) | 2.65913430 |
135 | thymic T cell selection (GO:0045061) | 2.62216252 |
136 | leukocyte aggregation (GO:0070486) | 2.60907950 |
137 | cellular response to interleukin-15 (GO:0071350) | 2.60148626 |
138 | negative regulation of type 2 immune response (GO:0002829) | 2.59673086 |
139 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.57871984 |
140 | T cell migration (GO:0072678) | 2.57745014 |
141 | regulation of necroptotic process (GO:0060544) | 2.55570600 |
142 | regulation of Rap GTPase activity (GO:0032317) | 2.54737472 |
143 | signal complex assembly (GO:0007172) | 2.51684496 |
144 | B cell receptor signaling pathway (GO:0050853) | 2.49315859 |
145 | myeloid dendritic cell differentiation (GO:0043011) | 2.48221272 |
146 | NIK/NF-kappaB signaling (GO:0038061) | 2.47611199 |
147 | regulation of type 2 immune response (GO:0002828) | 2.46481954 |
148 | positive regulation of type 2 immune response (GO:0002830) | 2.43116872 |
149 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.42454682 |
150 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.42132245 |
151 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.42132245 |
152 | modulation by symbiont of host immune response (GO:0052553) | 2.42132245 |
153 | positive regulation by symbiont of host defense response (GO:0052509) | 2.42132245 |
154 | modulation by symbiont of host defense response (GO:0052031) | 2.42132245 |
155 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.42132245 |
156 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.41981976 |
157 | regulation of T cell tolerance induction (GO:0002664) | 2.41130178 |
158 | response to peptidoglycan (GO:0032494) | 2.39370001 |
159 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.39092748 |
160 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.38646560 |
161 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.38646560 |
162 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.35225459 |
163 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.33095374 |
164 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.32155553 |
165 | positive regulation of tolerance induction (GO:0002645) | 2.29676953 |
166 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.29612469 |
167 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.29297325 |
168 | detection of molecule of bacterial origin (GO:0032490) | 2.28411946 |
169 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.27695679 |
170 | defense response to protozoan (GO:0042832) | 2.26654650 |
171 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.23001137 |
172 | T-helper cell differentiation (GO:0042093) | 2.23001137 |
173 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.22972519 |
174 | histone H3-K36 demethylation (GO:0070544) | 2.21670808 |
175 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.19057795 |
176 | regulation of tolerance induction (GO:0002643) | 2.17636371 |
177 | response to protozoan (GO:0001562) | 2.16813687 |
178 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.16767859 |
179 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.16112845 |
180 | protein localization to endosome (GO:0036010) | 2.15351175 |
181 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.14242322 |
182 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.12281969 |
183 | B cell proliferation (GO:0042100) | 2.12194344 |
184 | B cell homeostasis (GO:0001782) | 2.11323793 |
185 | positive regulation of interleukin-2 production (GO:0032743) | 2.11008189 |
186 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.10947722 |
187 | activation of MAPKKK activity (GO:0000185) | 2.09692337 |
188 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.09678500 |
189 | detection of other organism (GO:0098543) | 2.09102862 |
190 | regulation of chronic inflammatory response (GO:0002676) | 2.08349623 |
191 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.07861902 |
192 | response to nerve growth factor (GO:1990089) | 2.07861902 |
193 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.07484170 |
194 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.06838086 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.67313580 |
2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.66672003 |
3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.38397050 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.08914464 |
5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.92485043 |
6 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.85454372 |
7 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.80064923 |
8 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.76539297 |
9 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.65319121 |
10 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.51770251 |
11 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.51770251 |
12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.50514120 |
13 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.49495749 |
14 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.46723289 |
15 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.45070519 |
16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.37603013 |
17 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.35204451 |
18 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.32750010 |
19 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.29234354 |
20 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.28757051 |
21 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.28100788 |
22 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.25575865 |
23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.14317257 |
24 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.11933157 |
25 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.10520223 |
26 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.08137075 |
27 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.07653284 |
28 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.04681958 |
29 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.00720890 |
30 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.97538615 |
31 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.96964259 |
32 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.96822948 |
33 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.94935350 |
34 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.90958387 |
35 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.89928067 |
36 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.89236587 |
37 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.88484896 |
38 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.87762764 |
39 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.86214450 |
40 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.84754072 |
41 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.81443965 |
42 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.80678816 |
43 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.78353467 |
44 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.75048047 |
45 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.73109816 |
46 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.67309676 |
47 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.62860959 |
48 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.61352375 |
49 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.60584406 |
50 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.60298611 |
51 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.56982191 |
52 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.54943023 |
53 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.50483004 |
54 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.47843632 |
55 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.47156440 |
56 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.46747080 |
57 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.45702087 |
58 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.43691439 |
59 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.42121527 |
60 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.41713464 |
61 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.39633041 |
62 | SPI1_23127762_ChIP-Seq_K562_Human | 1.38492531 |
63 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.37730096 |
64 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.36781222 |
65 | TP53_16413492_ChIP-PET_HCT116_Human | 1.36537683 |
66 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.35196267 |
67 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.33054825 |
68 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.30028350 |
69 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.29649076 |
70 | * MYB_26560356_Chip-Seq_TH2_Human | 1.28927439 |
71 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.28549823 |
72 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.28395561 |
73 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.27967074 |
74 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.27367151 |
75 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.27293856 |
76 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.26602601 |
77 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.26338819 |
78 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.26271565 |
79 | GATA1_22025678_ChIP-Seq_K562_Human | 1.25729065 |
80 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.25705783 |
81 | AR_19668381_ChIP-Seq_PC3_Human | 1.24889765 |
82 | P300_19829295_ChIP-Seq_ESCs_Human | 1.24758597 |
83 | MAF_26560356_Chip-Seq_TH1_Human | 1.24152993 |
84 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.24146850 |
85 | STAT3_23295773_ChIP-Seq_U87_Human | 1.23957185 |
86 | AR_25329375_ChIP-Seq_VCAP_Human | 1.23654158 |
87 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.23485321 |
88 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.21185571 |
89 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.18731507 |
90 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.18381876 |
91 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.17172436 |
92 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.17052125 |
93 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.15979778 |
94 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.15480324 |
95 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.15237669 |
96 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.15175437 |
97 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.15099862 |
98 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15002848 |
99 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.14681125 |
100 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.14175810 |
101 | RXR_22108803_ChIP-Seq_LS180_Human | 1.13949437 |
102 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.13543554 |
103 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.12844282 |
104 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.12585050 |
105 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12249233 |
106 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.11231456 |
107 | TCF4_23295773_ChIP-Seq_U87_Human | 1.10907807 |
108 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.08681549 |
109 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08249021 |
110 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.08054202 |
111 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.07936071 |
112 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.07883237 |
113 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.07805884 |
114 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.07607053 |
115 | MYB_26560356_Chip-Seq_TH1_Human | 1.07516229 |
116 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.07370388 |
117 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.06698013 |
118 | GATA1_19941826_ChIP-Seq_K562_Human | 1.06573703 |
119 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.06382639 |
120 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.04379324 |
121 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.04341303 |
122 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.03967735 |
123 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.02222544 |
124 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.01884112 |
125 | * MYC_22102868_ChIP-Seq_BL_Human | 1.01713263 |
126 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.01231255 |
127 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.01107172 |
128 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.00996646 |
129 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.00780949 |
130 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.00737034 |
131 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.99843053 |
132 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.99112129 |
133 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.99020053 |
134 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 0.98721323 |
135 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.98028837 |
136 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97737260 |
137 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97693548 |
138 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.96847039 |
139 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.96644399 |
140 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.96220398 |
141 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.95931006 |
142 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.94727067 |
143 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94524072 |
144 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.94221845 |
145 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93799546 |
146 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.93697275 |
147 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.93179123 |
148 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92764166 |
149 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.92764166 |
150 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.92071894 |
151 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.91669943 |
152 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.91666335 |
153 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89838721 |
154 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89735923 |
155 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.89714501 |
156 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.89445143 |
157 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.89253642 |
158 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.89253642 |
159 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.88521093 |
160 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.88346245 |
161 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.86576443 |
162 | GATA2_19941826_ChIP-Seq_K562_Human | 0.85500289 |
163 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.85394479 |
164 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.85269828 |
165 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.85229746 |
166 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.85156135 |
167 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.84484857 |
168 | * UTX_26944678_Chip-Seq_JUKART_Human | 0.83544702 |
169 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.82788303 |
170 | MAF_26560356_Chip-Seq_TH2_Human | 0.80633551 |
171 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.80534051 |
172 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.80534051 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 7.44227148 |
2 | MP0003880_abnormal_central_pattern | 4.49617371 |
3 | MP0003635_abnormal_synaptic_transmissio | 4.35403403 |
4 | MP0004270_analgesia | 4.00794807 |
5 | MP0009745_abnormal_behavioral_response | 3.49875551 |
6 | MP0002063_abnormal_learning/memory/cond | 3.47103329 |
7 | MP0002064_seizures | 3.11330268 |
8 | MP0009046_muscle_twitch | 2.98647911 |
9 | MP0001968_abnormal_touch/_nociception | 2.89593991 |
10 | MP0003436_decreased_susceptibility_to | 2.89456500 |
11 | MP0003300_gastrointestinal_ulcer | 2.88960249 |
12 | MP0002572_abnormal_emotion/affect_behav | 2.80121306 |
13 | MP0003763_abnormal_thymus_physiology | 2.76526921 |
14 | MP0009780_abnormal_chondrocyte_physiolo | 2.73172893 |
15 | MP0002822_catalepsy | 2.72183538 |
16 | MP0003724_increased_susceptibility_to | 2.70636917 |
17 | MP0001486_abnormal_startle_reflex | 2.49387105 |
18 | MP0002734_abnormal_mechanical_nocicepti | 2.47467349 |
19 | MP0002272_abnormal_nervous_system | 2.45748869 |
20 | MP0001501_abnormal_sleep_pattern | 2.44050964 |
21 | MP0005423_abnormal_somatic_nervous | 2.36058082 |
22 | MP0005000_abnormal_immune_tolerance | 2.29286021 |
23 | MP0008569_lethality_at_weaning | 2.25076244 |
24 | MP0005387_immune_system_phenotype | 2.24456300 |
25 | MP0001790_abnormal_immune_system | 2.24456300 |
26 | MP0004947_skin_inflammation | 2.23895909 |
27 | MP0001835_abnormal_antigen_presentation | 2.18746518 |
28 | MP0001800_abnormal_humoral_immune | 2.12599892 |
29 | MP0002735_abnormal_chemical_nociception | 2.10465368 |
30 | MP0002736_abnormal_nociception_after | 2.09980467 |
31 | MP0001440_abnormal_grooming_behavior | 2.05161626 |
32 | MP0005451_abnormal_body_composition | 2.00806089 |
33 | MP0002332_abnormal_exercise_endurance | 2.00166566 |
34 | MP0005671_abnormal_response_to | 1.91955574 |
35 | MP0002067_abnormal_sensory_capabilities | 1.88589319 |
36 | MP0003091_abnormal_cell_migration | 1.87964828 |
37 | MP0002909_abnormal_adrenal_gland | 1.85802775 |
38 | MP0009785_altered_susceptibility_to | 1.84313940 |
39 | MP0003787_abnormal_imprinting | 1.83228371 |
40 | MP0002148_abnormal_hypersensitivity_rea | 1.83019580 |
41 | MP0002723_abnormal_immune_serum | 1.81937753 |
42 | MP0000685_abnormal_immune_system | 1.76421598 |
43 | MP0001970_abnormal_pain_threshold | 1.75427809 |
44 | MP0004811_abnormal_neuron_physiology | 1.73293810 |
45 | MP0002733_abnormal_thermal_nociception | 1.73019326 |
46 | MP0006082_CNS_inflammation | 1.72475802 |
47 | MP0004858_abnormal_nervous_system | 1.71310941 |
48 | MP0002419_abnormal_innate_immunity | 1.71086381 |
49 | MP0005025_abnormal_response_to | 1.70982458 |
50 | MP0002452_abnormal_antigen_presenting | 1.70363223 |
51 | MP0003329_amyloid_beta_deposits | 1.69083738 |
52 | MP0003879_abnormal_hair_cell | 1.68963040 |
53 | MP0002184_abnormal_innervation | 1.64872937 |
54 | MP0000569_abnormal_digit_pigmentation | 1.63976483 |
55 | MP0004924_abnormal_behavior | 1.61727263 |
56 | MP0005386_behavior/neurological_phenoty | 1.61727263 |
57 | MP0002420_abnormal_adaptive_immunity | 1.60946495 |
58 | MP0001819_abnormal_immune_cell | 1.58151639 |
59 | MP0002557_abnormal_social/conspecific_i | 1.57859773 |
60 | MP0004510_myositis | 1.55789939 |
61 | MP0000778_abnormal_nervous_system | 1.55627985 |
62 | MP0001533_abnormal_skeleton_physiology | 1.50679346 |
63 | MP0003633_abnormal_nervous_system | 1.48860421 |
64 | MP0002998_abnormal_bone_remodeling | 1.45669040 |
65 | MP0002405_respiratory_system_inflammati | 1.45520510 |
66 | MP0003453_abnormal_keratinocyte_physiol | 1.44162182 |
67 | MP0010155_abnormal_intestine_physiology | 1.43495828 |
68 | MP0003172_abnormal_lysosome_physiology | 1.41431593 |
69 | MP0001851_eye_inflammation | 1.39786985 |
70 | MP0000955_abnormal_spinal_cord | 1.38889300 |
71 | MP0000751_myopathy | 1.37935483 |
72 | MP0008961_abnormal_basal_metabolism | 1.37681424 |
73 | MP0005646_abnormal_pituitary_gland | 1.37473097 |
74 | MP0004145_abnormal_muscle_electrophysio | 1.35627890 |
75 | MP0008004_abnormal_stomach_pH | 1.33734220 |
76 | MP0005310_abnormal_salivary_gland | 1.31796149 |
77 | MP0002066_abnormal_motor_capabilities/c | 1.30919277 |
78 | * MP0002398_abnormal_bone_marrow | 1.24195446 |
79 | MP0002882_abnormal_neuron_morphology | 1.22985993 |
80 | MP0003045_fibrosis | 1.22872356 |
81 | MP0004885_abnormal_endolymph | 1.22690576 |
82 | MP0001502_abnormal_circadian_rhythm | 1.22577342 |
83 | MP0010352_gastrointestinal_tract_polyps | 1.22461235 |
84 | * MP0000716_abnormal_immune_system | 1.22286570 |
85 | MP0003631_nervous_system_phenotype | 1.16048822 |
86 | MP0001984_abnormal_olfaction | 1.14865279 |
87 | MP0009333_abnormal_splenocyte_physiolog | 1.14586984 |
88 | MP0001845_abnormal_inflammatory_respons | 1.13509886 |
89 | MP0001348_abnormal_lacrimal_gland | 1.13030462 |
90 | MP0004381_abnormal_hair_follicle | 1.11725772 |
91 | MP0003828_pulmonary_edema | 1.10943509 |
92 | MP0009764_decreased_sensitivity_to | 1.08476806 |
93 | MP0001853_heart_inflammation | 1.07624301 |
94 | MP0008874_decreased_physiological_sensi | 1.06910106 |
95 | MP0003075_altered_response_to | 1.06375934 |
96 | MP0003705_abnormal_hypodermis_morpholog | 1.05846627 |
97 | MP0001873_stomach_inflammation | 1.01420927 |
98 | MP0004484_altered_response_of | 1.01150984 |
99 | MP0003191_abnormal_cellular_cholesterol | 1.00633420 |
100 | MP0005645_abnormal_hypothalamus_physiol | 0.99632602 |
101 | MP0003866_abnormal_defecation | 0.99380431 |
102 | MP0001177_atelectasis | 0.97025207 |
103 | MP0002933_joint_inflammation | 0.96945200 |
104 | * MP0000703_abnormal_thymus_morphology | 0.95863518 |
105 | MP0002152_abnormal_brain_morphology | 0.95542996 |
106 | MP0005164_abnormal_response_to | 0.95082905 |
107 | MP0003448_altered_tumor_morphology | 0.94678690 |
108 | MP0005023_abnormal_wound_healing | 0.93529563 |
109 | MP0005464_abnormal_platelet_physiology | 0.92424751 |
110 | MP0002166_altered_tumor_susceptibility | 0.91808995 |
111 | MP0003656_abnormal_erythrocyte_physiolo | 0.90193600 |
112 | MP0000465_gastrointestinal_hemorrhage | 0.89947613 |
113 | MP0008260_abnormal_autophagy | 0.89304899 |
114 | MP0005076_abnormal_cell_differentiation | 0.88877223 |
115 | MP0001188_hyperpigmentation | 0.88454606 |
116 | MP0004085_abnormal_heartbeat | 0.88069927 |
117 | MP0002009_preneoplasia | 0.87368893 |
118 | MP0000013_abnormal_adipose_tissue | 0.87266017 |
119 | MP0002069_abnormal_eating/drinking_beha | 0.86483291 |
120 | MP0000858_altered_metastatic_potential | 0.86356510 |
121 | MP0003303_peritoneal_inflammation | 0.86205053 |
122 | MP0009278_abnormal_bone_marrow | 0.85315461 |
123 | MP0003183_abnormal_peptide_metabolism | 0.85283227 |
124 | MP0002722_abnormal_immune_system | 0.85134347 |
125 | MP0008872_abnormal_physiological_respon | 0.84852597 |
126 | MP0000604_amyloidosis | 0.84545579 |
127 | MP0002006_tumorigenesis | 0.83758416 |
128 | MP0002837_dystrophic_cardiac_calcinosis | 0.82835431 |
129 | MP0004215_abnormal_myocardial_fiber | 0.81918041 |
130 | MP0005409_darkened_coat_color | 0.81301743 |
131 | MP0003566_abnormal_cell_adhesion | 0.81166505 |
132 | MP0005535_abnormal_body_temperature | 0.80354279 |
133 | MP0004742_abnormal_vestibular_system | 0.80330867 |
134 | MP0001299_abnormal_eye_distance/ | 0.80015608 |
135 | * MP0002429_abnormal_blood_cell | 0.79721389 |
136 | MP0000689_abnormal_spleen_morphology | 0.79057909 |
137 | MP0004808_abnormal_hematopoietic_stem | 0.78972614 |
138 | MP0000733_abnormal_muscle_development | 0.78880100 |
139 | MP0005666_abnormal_adipose_tissue | 0.78481614 |
140 | MP0008469_abnormal_protein_level | 0.75998440 |
141 | MP0004130_abnormal_muscle_cell | 0.75809116 |
142 | MP0006276_abnormal_autonomic_nervous | 0.75754659 |
143 | MP0003279_aneurysm | 0.74907521 |
144 | MP0009840_abnormal_foam_cell | 0.74603821 |
145 | MP0005375_adipose_tissue_phenotype | 0.74149919 |
146 | MP0004142_abnormal_muscle_tone | 0.74111096 |
147 | MP0010234_abnormal_vibrissa_follicle | 0.73569862 |
148 | MP0003690_abnormal_glial_cell | 0.73248510 |
149 | MP0001905_abnormal_dopamine_level | 0.69756387 |
150 | MP0002234_abnormal_pharynx_morphology | 0.68421723 |
151 | MP0000920_abnormal_myelination | 0.67099980 |
152 | MP0002229_neurodegeneration | 0.67030330 |
153 | MP0003632_abnormal_nervous_system | 0.66517558 |
154 | MP0004233_abnormal_muscle_weight | 0.66350268 |
155 | MP0005623_abnormal_meninges_morphology | 0.65972765 |
156 | MP0005167_abnormal_blood-brain_barrier | 0.64878343 |
157 | MP0010386_abnormal_urinary_bladder | 0.61445173 |
158 | MP0001963_abnormal_hearing_physiology | 0.60979529 |
159 | MP0003634_abnormal_glial_cell | 0.60587201 |
160 | MP0002090_abnormal_vision | 0.59969420 |
161 | MP0003646_muscle_fatigue | 0.59387248 |
162 | MP0005620_abnormal_muscle_contractility | 0.58583859 |
163 | MP0003137_abnormal_impulse_conducting | 0.55301317 |
164 | MP0005187_abnormal_penis_morphology | 0.54544436 |
165 | MP0003283_abnormal_digestive_organ | 0.53354548 |
166 | MP0000747_muscle_weakness | 0.53193444 |
167 | MP0001943_abnormal_respiration | 0.53149592 |
168 | MP0005499_abnormal_olfactory_system | 0.52627527 |
169 | MP0005394_taste/olfaction_phenotype | 0.52627527 |
170 | MP0010769_abnormal_survival | 0.52236185 |
171 | MP0005166_decreased_susceptibility_to | 0.51140988 |
172 | MP0001664_abnormal_digestion | 0.50327893 |
173 | MP0001529_abnormal_vocalization | 0.50315791 |
174 | MP0005551_abnormal_eye_electrophysiolog | 0.49508467 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 7.68202891 |
2 | Myokymia (HP:0002411) | 6.25577700 |
3 | Focal seizures (HP:0007359) | 5.72636311 |
4 | Epileptic encephalopathy (HP:0200134) | 4.81769913 |
5 | Visual hallucinations (HP:0002367) | 4.67718380 |
6 | Febrile seizures (HP:0002373) | 4.44639690 |
7 | Atonic seizures (HP:0010819) | 4.33457269 |
8 | Progressive cerebellar ataxia (HP:0002073) | 4.31228359 |
9 | Action tremor (HP:0002345) | 4.15636970 |
10 | Absence seizures (HP:0002121) | 3.97846733 |
11 | Broad-based gait (HP:0002136) | 3.84730751 |
12 | Gaze-evoked nystagmus (HP:0000640) | 3.63689105 |
13 | Dialeptic seizures (HP:0011146) | 3.59551841 |
14 | Generalized tonic-clonic seizures (HP:0002069) | 3.57250271 |
15 | Poor eye contact (HP:0000817) | 3.40380541 |
16 | Eczematoid dermatitis (HP:0000976) | 3.35010138 |
17 | Papilledema (HP:0001085) | 3.31722839 |
18 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.29905280 |
19 | Hyperventilation (HP:0002883) | 3.27232278 |
20 | Genetic anticipation (HP:0003743) | 3.22735169 |
21 | Dysmetric saccades (HP:0000641) | 3.22221585 |
22 | Optic neuritis (HP:0100653) | 3.20398443 |
23 | Retrobulbar optic neuritis (HP:0100654) | 3.20398443 |
24 | Dysdiadochokinesis (HP:0002075) | 3.15709203 |
25 | Orchitis (HP:0100796) | 3.14144311 |
26 | T lymphocytopenia (HP:0005403) | 3.14062825 |
27 | Impaired social interactions (HP:0000735) | 3.11714155 |
28 | Abnormal social behavior (HP:0012433) | 3.11714155 |
29 | Dysmetria (HP:0001310) | 3.11389026 |
30 | Impaired smooth pursuit (HP:0007772) | 3.11047412 |
31 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.10283342 |
32 | Truncal ataxia (HP:0002078) | 3.05523395 |
33 | Myositis (HP:0100614) | 2.95260293 |
34 | Supranuclear gaze palsy (HP:0000605) | 2.94502416 |
35 | Abnormality of T cell number (HP:0011839) | 2.91113812 |
36 | Depression (HP:0000716) | 2.87480430 |
37 | Excessive salivation (HP:0003781) | 2.77316427 |
38 | Drooling (HP:0002307) | 2.77316427 |
39 | Amblyopia (HP:0000646) | 2.76894062 |
40 | Postural instability (HP:0002172) | 2.75756479 |
41 | Scanning speech (HP:0002168) | 2.74741904 |
42 | Stomatitis (HP:0010280) | 2.72905238 |
43 | Stereotypic behavior (HP:0000733) | 2.71827193 |
44 | Ankle clonus (HP:0011448) | 2.70115902 |
45 | Abnormality of binocular vision (HP:0011514) | 2.69424691 |
46 | Diplopia (HP:0000651) | 2.69424691 |
47 | Urinary urgency (HP:0000012) | 2.67729026 |
48 | Lower limb amyotrophy (HP:0007210) | 2.63740428 |
49 | Slow saccadic eye movements (HP:0000514) | 2.62728449 |
50 | Hemiplegia (HP:0002301) | 2.62194433 |
51 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.60860818 |
52 | Recurrent bacterial skin infections (HP:0005406) | 2.55092253 |
53 | Anxiety (HP:0000739) | 2.54242430 |
54 | Abnormal eating behavior (HP:0100738) | 2.46748774 |
55 | Abnormality of the lower motor neuron (HP:0002366) | 2.44574642 |
56 | Keratoconjunctivitis sicca (HP:0001097) | 2.43893782 |
57 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.42009026 |
58 | Bundle branch block (HP:0011710) | 2.39877880 |
59 | Mediastinal lymphadenopathy (HP:0100721) | 2.39724065 |
60 | Vasculitis (HP:0002633) | 2.38357222 |
61 | Epileptiform EEG discharges (HP:0011182) | 2.37922343 |
62 | Intention tremor (HP:0002080) | 2.36115493 |
63 | Mutism (HP:0002300) | 2.34639685 |
64 | Autoimmune hemolytic anemia (HP:0001890) | 2.33753364 |
65 | Impaired vibratory sensation (HP:0002495) | 2.31839918 |
66 | Hemiparesis (HP:0001269) | 2.28132148 |
67 | Fetal akinesia sequence (HP:0001989) | 2.26594470 |
68 | Subacute progressive viral hepatitis (HP:0006572) | 2.25397919 |
69 | Torticollis (HP:0000473) | 2.23287824 |
70 | Absent speech (HP:0001344) | 2.20662871 |
71 | Pointed chin (HP:0000307) | 2.20423562 |
72 | Increased IgE level (HP:0003212) | 2.20417416 |
73 | Megalencephaly (HP:0001355) | 2.20085227 |
74 | Hyporeflexia of lower limbs (HP:0002600) | 2.18915345 |
75 | Difficulty running (HP:0009046) | 2.18887408 |
76 | Gastrointestinal infarctions (HP:0005244) | 2.18740174 |
77 | Obstructive sleep apnea (HP:0002870) | 2.17919869 |
78 | Keratoconjunctivitis (HP:0001096) | 2.17333347 |
79 | Annular pancreas (HP:0001734) | 2.15166194 |
80 | EEG with generalized epileptiform discharges (HP:0011198) | 2.14259826 |
81 | Abnormality of macrophages (HP:0004311) | 2.12502645 |
82 | Progressive inability to walk (HP:0002505) | 2.10866096 |
83 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.10754866 |
84 | Pulmonary infiltrates (HP:0002113) | 2.10557628 |
85 | Gingivitis (HP:0000230) | 2.09219157 |
86 | Termporal pattern (HP:0011008) | 2.08804401 |
87 | Insidious onset (HP:0003587) | 2.08804401 |
88 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.08749230 |
89 | Subaortic stenosis (HP:0001682) | 2.08749230 |
90 | Spastic gait (HP:0002064) | 2.08631030 |
91 | Bradykinesia (HP:0002067) | 2.08607070 |
92 | Ventricular fibrillation (HP:0001663) | 2.07812200 |
93 | Cerebral inclusion bodies (HP:0100314) | 2.05627783 |
94 | Interstitial pulmonary disease (HP:0006530) | 2.03408552 |
95 | Recurrent abscess formation (HP:0002722) | 2.02870746 |
96 | Focal dystonia (HP:0004373) | 2.02626635 |
97 | Lower limb asymmetry (HP:0100559) | 1.99936071 |
98 | Status epilepticus (HP:0002133) | 1.99668081 |
99 | Recurrent fungal infections (HP:0002841) | 1.99310989 |
100 | Abnormality of the fingertips (HP:0001211) | 1.99040146 |
101 | Hypsarrhythmia (HP:0002521) | 1.98573462 |
102 | Neuronal loss in central nervous system (HP:0002529) | 1.98397624 |
103 | Spontaneous hematomas (HP:0007420) | 1.98310007 |
104 | Inappropriate behavior (HP:0000719) | 1.98279602 |
105 | Overgrowth (HP:0001548) | 1.97991135 |
106 | Type 1 muscle fiber predominance (HP:0003803) | 1.96498207 |
107 | Blue irides (HP:0000635) | 1.96397924 |
108 | Ankyloglossia (HP:0010296) | 1.95453204 |
109 | Aqueductal stenosis (HP:0002410) | 1.94479720 |
110 | Recurrent viral infections (HP:0004429) | 1.94465112 |
111 | Muscle fiber inclusion bodies (HP:0100299) | 1.91274211 |
112 | Lower limb muscle weakness (HP:0007340) | 1.91071530 |
113 | Abnormality of salivation (HP:0100755) | 1.90125064 |
114 | Exercise-induced myalgia (HP:0003738) | 1.89547602 |
115 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.89387233 |
116 | Colitis (HP:0002583) | 1.88072590 |
117 | Inability to walk (HP:0002540) | 1.87917079 |
118 | Gastrointestinal stroma tumor (HP:0100723) | 1.87799646 |
119 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.86410813 |
120 | Abnormal EKG (HP:0003115) | 1.85985270 |
121 | Protruding tongue (HP:0010808) | 1.84361903 |
122 | Recurrent bronchitis (HP:0002837) | 1.83928101 |
123 | Macroorchidism (HP:0000053) | 1.83865556 |
124 | Nemaline bodies (HP:0003798) | 1.83787352 |
125 | Pustule (HP:0200039) | 1.83762603 |
126 | Chest pain (HP:0100749) | 1.83128851 |
127 | Incomplete penetrance (HP:0003829) | 1.83007705 |
128 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.80685957 |
129 | Resting tremor (HP:0002322) | 1.80201089 |
130 | Onion bulb formation (HP:0003383) | 1.79989743 |
131 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.79712303 |
132 | Gait ataxia (HP:0002066) | 1.79039673 |
133 | Disinhibition (HP:0000734) | 1.78735662 |
134 | Abnormality of saccadic eye movements (HP:0000570) | 1.78518491 |
135 | Neurofibrillary tangles (HP:0002185) | 1.78312339 |
136 | Spondylolisthesis (HP:0003302) | 1.77715770 |
137 | Aortic aneurysm (HP:0004942) | 1.77324709 |
138 | Autoimmune thrombocytopenia (HP:0001973) | 1.76922329 |
139 | Deeply set eye (HP:0000490) | 1.76357290 |
140 | Muscle fiber splitting (HP:0003555) | 1.75444638 |
141 | Arterial tortuosity (HP:0005116) | 1.75105337 |
142 | Widely spaced teeth (HP:0000687) | 1.74773587 |
143 | Asymmetric septal hypertrophy (HP:0001670) | 1.74096246 |
144 | Apathy (HP:0000741) | 1.73587646 |
145 | Dysostosis multiplex (HP:0000943) | 1.73222414 |
146 | Rapidly progressive (HP:0003678) | 1.72909877 |
147 | Spinal canal stenosis (HP:0003416) | 1.72851348 |
148 | Hemoptysis (HP:0002105) | 1.70953506 |
149 | Arterial thrombosis (HP:0004420) | 1.70672816 |
150 | Meningitis (HP:0001287) | 1.70415604 |
151 | Cellulitis (HP:0100658) | 1.69733233 |
152 | Distal lower limb amyotrophy (HP:0008944) | 1.69189775 |
153 | Gangrene (HP:0100758) | 1.68559579 |
154 | Emphysema (HP:0002097) | 1.68095910 |
155 | Craniofacial dystonia (HP:0012179) | 1.68008058 |
156 | Peritonitis (HP:0002586) | 1.68002527 |
157 | Absent frontal sinuses (HP:0002688) | 1.67983164 |
158 | Abnormality of the corticospinal tract (HP:0002492) | 1.67506298 |
159 | Recurrent skin infections (HP:0001581) | 1.66978962 |
160 | Prolonged QT interval (HP:0001657) | 1.66681609 |
161 | Decreased motor nerve conduction velocity (HP:0003431) | 1.63802280 |
162 | Abnormality of the periventricular white matter (HP:0002518) | 1.63061706 |
163 | Sudden death (HP:0001699) | 1.62978412 |
164 | Increased variability in muscle fiber diameter (HP:0003557) | 1.62813111 |
165 | Open mouth (HP:0000194) | 1.62120612 |
166 | Increased connective tissue (HP:0009025) | 1.61880061 |
167 | Generalized myoclonic seizures (HP:0002123) | 1.61756104 |
168 | Frequent falls (HP:0002359) | 1.61468091 |
169 | Vascular tortuosity (HP:0004948) | 1.61413326 |
170 | Leukocytosis (HP:0001974) | 1.61202368 |
171 | Dislocated radial head (HP:0003083) | 1.61119989 |
172 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.59454672 |
173 | Inflammation of the large intestine (HP:0002037) | 1.58710883 |
174 | Generalized hypopigmentation of hair (HP:0011358) | 1.58412514 |
175 | Vertigo (HP:0002321) | 1.57571824 |
176 | Abnormality of T cells (HP:0002843) | 1.56593817 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EPHA4 | 4.75877909 |
2 | NTRK3 | 4.48441648 |
3 | MAP3K9 | 3.56649720 |
4 | DAPK2 | 2.84807027 |
5 | MAP3K4 | 2.71472006 |
6 | RIPK4 | 2.56536003 |
7 | MARK1 | 2.46088058 |
8 | MAP4K1 | 2.39253050 |
9 | MINK1 | 2.33750701 |
10 | MAP3K14 | 2.18713605 |
11 | PAK6 | 2.12433602 |
12 | MAP2K7 | 2.08261156 |
13 | CAMKK1 | 1.99297558 |
14 | IRAK3 | 1.97296208 |
15 | PRKD3 | 1.94950467 |
16 | KSR2 | 1.94945092 |
17 | NTRK2 | 1.94685908 |
18 | DAPK1 | 1.75652675 |
19 | SIK2 | 1.73192288 |
20 | TXK | 1.71944436 |
21 | KSR1 | 1.66067150 |
22 | MAP2K4 | 1.65737746 |
23 | IKBKE | 1.65530663 |
24 | PRPF4B | 1.64884004 |
25 | CDK12 | 1.63870718 |
26 | TYK2 | 1.58335907 |
27 | NTRK1 | 1.55155024 |
28 | CDK5 | 1.50429386 |
29 | CASK | 1.49631144 |
30 | TNIK | 1.47499793 |
31 | MAP3K13 | 1.47072961 |
32 | TAOK1 | 1.44941635 |
33 | CSK | 1.35627909 |
34 | ZAP70 | 1.34857813 |
35 | STK38 | 1.32358213 |
36 | BLK | 1.32300950 |
37 | PLK2 | 1.32140866 |
38 | FES | 1.31095456 |
39 | CAMKK2 | 1.30192288 |
40 | FGFR4 | 1.27416509 |
41 | MAP3K2 | 1.26975145 |
42 | MAP3K3 | 1.24799142 |
43 | TYRO3 | 1.22387142 |
44 | MAP3K12 | 1.22037672 |
45 | TBK1 | 1.18886170 |
46 | MAP2K3 | 1.14107440 |
47 | PRKCH | 1.13261188 |
48 | MAPK13 | 1.12950111 |
49 | CDK19 | 1.10592532 |
50 | TAOK2 | 1.10004692 |
51 | PRKCG | 1.09770968 |
52 | RIPK1 | 1.05765733 |
53 | CAMK1 | 1.04770378 |
54 | SGK2 | 1.03904376 |
55 | OBSCN | 1.03682694 |
56 | JAK3 | 1.03608319 |
57 | SGK3 | 1.02499272 |
58 | TTN | 1.02380890 |
59 | AKT3 | 1.01682915 |
60 | NLK | 1.01286590 |
61 | DMPK | 1.01090200 |
62 | PTK2B | 1.00821998 |
63 | MAP3K7 | 1.00113340 |
64 | STK11 | 1.00066947 |
65 | BMPR2 | 0.99600836 |
66 | ERN1 | 0.99160847 |
67 | IRAK4 | 0.98778736 |
68 | MOS | 0.98220326 |
69 | GRK5 | 0.97943383 |
70 | RET | 0.97801150 |
71 | JAK2 | 0.97234301 |
72 | MARK2 | 0.95163438 |
73 | IKBKB | 0.94505522 |
74 | PDGFRA | 0.93773180 |
75 | CAMK2A | 0.93330997 |
76 | PDK1 | 0.92851233 |
77 | SYK | 0.91559497 |
78 | CAMK1G | 0.91391345 |
79 | HIPK2 | 0.90701892 |
80 | SGK223 | 0.90631460 |
81 | SGK494 | 0.90631460 |
82 | SGK1 | 0.89250276 |
83 | EPHB1 | 0.88690816 |
84 | ICK | 0.86934030 |
85 | MAP3K10 | 0.86292615 |
86 | RAF1 | 0.86194254 |
87 | PDGFRB | 0.84546279 |
88 | PHKG2 | 0.83711503 |
89 | PHKG1 | 0.83711503 |
90 | BTK | 0.83611019 |
91 | PNCK | 0.83593922 |
92 | HCK | 0.83152879 |
93 | CHUK | 0.81860348 |
94 | ITK | 0.81054215 |
95 | EPHA3 | 0.79751505 |
96 | DDR2 | 0.78886213 |
97 | CAMK2B | 0.78836254 |
98 | IRAK2 | 0.78180870 |
99 | GRK7 | 0.77567451 |
100 | TRIB3 | 0.77015034 |
101 | TGFBR2 | 0.75360727 |
102 | ALK | 0.74649714 |
103 | PDPK1 | 0.73234599 |
104 | MAP3K11 | 0.72086440 |
105 | FGR | 0.70051935 |
106 | LCK | 0.69278123 |
107 | CDK18 | 0.65965703 |
108 | CDK15 | 0.64046169 |
109 | TRPM7 | 0.63738218 |
110 | MAP3K1 | 0.63627314 |
111 | DYRK1A | 0.63072431 |
112 | PAK3 | 0.62868086 |
113 | UHMK1 | 0.59957157 |
114 | MAPK12 | 0.59473023 |
115 | CAMK4 | 0.59313540 |
116 | FYN | 0.58768066 |
117 | CDK14 | 0.57518934 |
118 | IRAK1 | 0.56850441 |
119 | TAOK3 | 0.56613117 |
120 | MELK | 0.54002688 |
121 | LMTK2 | 0.53896665 |
122 | ARAF | 0.53598043 |
123 | CDK11A | 0.53266803 |
124 | MAPK11 | 0.53192833 |
125 | CDC42BPA | 0.53064855 |
126 | RPS6KA3 | 0.52835894 |
127 | SIK1 | 0.52814512 |
128 | NEK6 | 0.52587992 |
129 | FGFR2 | 0.52344563 |
130 | BRD4 | 0.51633584 |
131 | CAMK1D | 0.49923157 |
132 | STK24 | 0.49617889 |
133 | JAK1 | 0.48819882 |
134 | TNK2 | 0.48151929 |
135 | MAPK4 | 0.48068993 |
136 | MARK3 | 0.47330504 |
137 | MAPK10 | 0.46022390 |
138 | LATS2 | 0.45327000 |
139 | MAP3K6 | 0.44674369 |
140 | SIK3 | 0.44484659 |
141 | MAPK7 | 0.43897386 |
142 | FGFR3 | 0.43681018 |
143 | WNK1 | 0.43626720 |
144 | PRKCE | 0.42832696 |
145 | CSNK1G2 | 0.41722045 |
146 | FER | 0.41340672 |
147 | CCNB1 | 0.39943941 |
148 | PRKCQ | 0.39853803 |
149 | PRKCZ | 0.39197397 |
150 | PINK1 | 0.38658939 |
151 | OXSR1 | 0.34124873 |
152 | NME1 | 0.33822813 |
153 | PRKCB | 0.33368902 |
154 | DAPK3 | 0.32692282 |
155 | MAP2K1 | 0.32596496 |
156 | CAMK2D | 0.32460809 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.18011573 |
2 | Long-term potentiation_Homo sapiens_hsa04720 | 2.70023245 |
3 | Circadian entrainment_Homo sapiens_hsa04713 | 2.57118800 |
4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.45494612 |
5 | Olfactory transduction_Homo sapiens_hsa04740 | 2.43274217 |
6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.40173103 |
7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.35126373 |
8 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.28669326 |
9 | Morphine addiction_Homo sapiens_hsa05032 | 2.23742919 |
10 | Salivary secretion_Homo sapiens_hsa04970 | 2.18435159 |
11 | GABAergic synapse_Homo sapiens_hsa04727 | 2.17753468 |
12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.94517852 |
13 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.91534501 |
14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.89799610 |
15 | Insulin secretion_Homo sapiens_hsa04911 | 1.88920024 |
16 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.84502938 |
17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.80367009 |
18 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.74199154 |
19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.73237631 |
20 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.71261006 |
21 | Renin secretion_Homo sapiens_hsa04924 | 1.71139200 |
22 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.64568767 |
23 | Long-term depression_Homo sapiens_hsa04730 | 1.61618789 |
24 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.61067178 |
25 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.60342898 |
26 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.55598398 |
27 | Leishmaniasis_Homo sapiens_hsa05140 | 1.46860401 |
28 | Taste transduction_Homo sapiens_hsa04742 | 1.46759127 |
29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.43646318 |
30 | Cocaine addiction_Homo sapiens_hsa05030 | 1.39861613 |
31 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.37999082 |
32 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.36311662 |
33 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.35621677 |
34 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.35292209 |
35 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.34995634 |
36 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.33350673 |
37 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.33035817 |
38 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.29991829 |
39 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.28976153 |
40 | Glioma_Homo sapiens_hsa05214 | 1.25792897 |
41 | Tuberculosis_Homo sapiens_hsa05152 | 1.23611481 |
42 | Measles_Homo sapiens_hsa05162 | 1.22546719 |
43 | Gap junction_Homo sapiens_hsa04540 | 1.21361484 |
44 | Malaria_Homo sapiens_hsa05144 | 1.20441764 |
45 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.20097852 |
46 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.18400560 |
47 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.18289952 |
48 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.15935206 |
49 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.15589727 |
50 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.14140139 |
51 | Allograft rejection_Homo sapiens_hsa05330 | 1.13962631 |
52 | Influenza A_Homo sapiens_hsa05164 | 1.12793919 |
53 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.10079721 |
54 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.08285560 |
55 | Hepatitis B_Homo sapiens_hsa05161 | 1.06141465 |
56 | Hepatitis C_Homo sapiens_hsa05160 | 1.04847217 |
57 | Axon guidance_Homo sapiens_hsa04360 | 1.03838771 |
58 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.03364355 |
59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.00197386 |
60 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.98958135 |
61 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.98378963 |
62 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.98309810 |
63 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.98069250 |
64 | Melanogenesis_Homo sapiens_hsa04916 | 0.97180118 |
65 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.96778784 |
66 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.94851032 |
67 | Pertussis_Homo sapiens_hsa05133 | 0.94389046 |
68 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.93692455 |
69 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.92947423 |
70 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.92107661 |
71 | Amoebiasis_Homo sapiens_hsa05146 | 0.90718383 |
72 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.90080146 |
73 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.87504077 |
74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.85314008 |
75 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.85102404 |
76 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.84794654 |
77 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.84714200 |
78 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.84470363 |
79 | Legionellosis_Homo sapiens_hsa05134 | 0.84107221 |
80 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.83390026 |
81 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.81603181 |
82 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.80891060 |
83 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.80734380 |
84 | Prion diseases_Homo sapiens_hsa05020 | 0.80079487 |
85 | Salmonella infection_Homo sapiens_hsa05132 | 0.79129926 |
86 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.77764982 |
87 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.77473888 |
88 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.77398928 |
89 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.75901611 |
90 | Insulin resistance_Homo sapiens_hsa04931 | 0.75512771 |
91 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.75508108 |
92 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.75292640 |
93 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.75283625 |
94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.74917347 |
95 | Circadian rhythm_Homo sapiens_hsa04710 | 0.74514027 |
96 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.74405573 |
97 | Viral myocarditis_Homo sapiens_hsa05416 | 0.71939060 |
98 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.71118663 |
99 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.70669133 |
100 | Prostate cancer_Homo sapiens_hsa05215 | 0.69992451 |
101 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.68952897 |
102 | Apoptosis_Homo sapiens_hsa04210 | 0.67722121 |
103 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.67444617 |
104 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.67312805 |
105 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.66799704 |
106 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.65548740 |
107 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.64848072 |
108 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.63829967 |
109 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.63618682 |
110 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.63382661 |
111 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.62362526 |
112 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.62011114 |
113 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.61337624 |
114 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60608824 |
115 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.59829809 |
116 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.59091450 |
117 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.58922973 |
118 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.58172987 |
119 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.55791811 |
120 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.55607843 |
121 | Endometrial cancer_Homo sapiens_hsa05213 | 0.55575018 |
122 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.55537023 |
123 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.55098443 |
124 | Platelet activation_Homo sapiens_hsa04611 | 0.53782938 |
125 | Endocytosis_Homo sapiens_hsa04144 | 0.52143578 |
126 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.51345238 |
127 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.51094428 |
128 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.49343297 |
129 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.49234376 |
130 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.45479550 |
131 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.45122303 |
132 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.44533317 |
133 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.42974089 |
134 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.41245789 |
135 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.40427046 |
136 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.39813865 |
137 | Colorectal cancer_Homo sapiens_hsa05210 | 0.39431328 |
138 | Phototransduction_Homo sapiens_hsa04744 | 0.38709215 |
139 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.38681123 |
140 | Bile secretion_Homo sapiens_hsa04976 | 0.38678140 |
141 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.37489136 |